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Madeleine Duc Dodon1*
From 15th International Conference on Human Retroviruses: HTLV and Related Viruses
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Alteration of early haematopoietic development is
thought to be responsible for the onset of immature leu-
kemias and lymphomas. We have previously shown that
HTLV-1 (Human T cell Leukemia Virus type 1) is able
not only to infect immature thymocytes in vitro but
also, through Tax expression, to alter the b-selection
checkpoint critical for early T cell development. To
further clarify the role of the natural HTLV-1 infection
on human T-cell development, we developed an in vivo
model by transplanting immunocompromised Rag2-/-
gc-/- newborn mice with human cord blood CD34+
cells to obtain Human Immune System (HIS) mice. In
these mice the development of human T cells in the
thymus is fully developed within two months after
human cell transplantation. Lethally irradiated HTLV-1
producing cells were then injected into these HIS mice.
Herein we observed in the thymus of the infected ani-
mals an enlarged population of mature T cells when
compared with the mock-infected mice. Furthermore,
we noted an increased number of CD4+ cells expressing
CD25. Infected animals also developed, several weeks
after the infection, pathological features such as spleno-
megaly, adenopathy, thymomas, lymphomas and leuke-
mias in which predominate human T cells, with a large
proportion of CD25+ activated cells. Tax expression
especially in the lymphomas and thymomas correlated
with an up-regulation of NF-B regulated genes. Alto-
gether, these results underline that this HIS Rag2-/-gc-/-
model might be of great interest to study the
leukemogenic process induced by HTLV-1 as well as to
validate new therapeutic approaches of ATL.
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